CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Suda Pharmaceuticals Ltd Company Snapshot
Suda Pharmaceuticals Ltd, formerly Suda Limited is a drug delivery company, which is engaged in pharmaceutical development of drug delivery technology, and medical devices and consumables distribution. Its segments are Suda, Westcoast Surgical & Medical Supplies (Westcoast), Malaria Research Company (MRC) and Other. The Suda segment is engaged in research and development to create new human pharmaceutical products by combining drugs with delivery technologies. The Westcoast segment is engaged in sales and logistics operation for medical devices and consumables. The MRC segment is pharmaceutical development segment for the treatment of malaria, including ArTiMist project. ArTiMist is a sublingual spray for the treatment of Plasmodium falciparum severe pediatric malaria. Its other pipeline of products includes Zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its development stage products include orals sprays for the treatment of migraine headache and erectile dysfunction.

Sales Analysis. Suda Pharmaceuticals Ltd reported sales of A$7.22 million (US$5.43 million) for the fiscal year ending June of 2017. This represents an increase of 23.0% versus 2016, when the company's sales were A$5.87 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Suda Pharmaceuticals Ltd
  Stock Performance Chart for Suda Pharmaceuticals Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): .02
(Figures in Australian Dollars)
1 Week 6.7%   13 Weeks -15.8%  
4 Weeks -30.4%   52 Weeks -15.8%  
 
Suda Pharmaceuticals Ltd Key Data:
  Ticker: SUD Country: Australia
  Exchanges: FRA OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Medical & Hospital Equipment
  2017 Sales 7,221,385
(Year Ending Jan 2018).
Employees: 44
  Currency: Australian Dollars Market Cap: 19,517,736
  Fiscal Yr Ends: June Shares Outstanding: 1,219,858,520
  Share Type: Ordinary Closely Held Shares: 165,071,655
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.